JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB269897

Atto 565 Conjugation Kit (Fast) - Lightning-Link®

Be the first to review this product! Submit a review

|

(3 Publications)

Atto 565 Conjugation Kit (Fast) - Lightning-Link® (ab269897) offers several standout features:

- Rapid Conjugation: achieve Atto 565 labeling in under 2 hours with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. Atto 565-labeled antibodies can be used immediately in applications such as Western blot, Flow cytometry, ELISA, and Immunohistochemistry (IHC) without further purification.
2 Images
Schematic Diagram - Atto 565 Conjugation Kit (Fast) - Lightning-Link® (AB269897)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab269897 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Functional Studies - Atto 565 Conjugation Kit (Fast) - Lightning-Link® (AB269897)
  • FuncS

Supplier Data

Atto 565 Conjugation Kit (Fast) - Lightning-Link® absorbance emission graph.

++ This peak is an absorbance peak rather that a fluorescence excitation peak, so the dye will not fluoresce if excitation wavelengths in this range are used.

Key facts

Product details

Atto 565 Conjugation Kit (Fast) - Lightning-Link® (ab269897) provides an easy-to-use, one step procedure that allows researchers to covalently label proteins, peptides and other biomolecules containing primary amines with Atto 565 with only 30 seconds hands-on time; furthermore conjugates are ready to use in less than twenty minutes.

The antibody to be labeled should be purified, in an appropriate buffer for conjugation and at a suitable concentration.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits. Use the FAQ to learn more about the technology, or about conjugating other proteins and peptides to Atto 565.

Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid Atto 565 Labeling Kit. 351-0005 is the same as the 100 μg size. 351-0010 is the same as the 3 x 100 ug size. 351-0030 is the same as the 3 x 10 ug size.

Amount and volume of antibody for conjugation to Atto 565

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 μg 3 x 10 μg 3 x 20 μg 3 x 10 μL
100 μg 100 μg 200 μg 100 μL
3 x 100 μg 3 x 100 μg 3 x 200 μg 3 x 100 μL

1 Using the maximum amount of antibody may result in less labeling per antibody.

2 Ideal antibody concentration is 1mg/ml. 0.5 - 1 mg/ml can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/ml or < 0.5 mg/ml should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab269897-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB269897-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB269897-CMP02" }, { "size":"3 x 10 µg", "name":"Atto 565 mix (Lyophilized)", "number":"AB269897-CMP01" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab269897-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB269897-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB269897-CMP02" }, { "size":"3 x 100 µg", "name":"Atto 565 mix (Lyophilized)", "number":"AB269897-CMP01" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab269897-100ug", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Atto 565 mix (Lyophilized)", "number":"AB269897-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB269897-CMP02", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB269897-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Nature medicine 24:1225-1233 PubMed29892068

2018

Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure.

Applications

Unspecified application

Species

Unspecified reactive species

Christina Yingxian Chen,Matthew A Caporizzo,Kenneth Bedi,Alexia Vite,Alexey I Bogush,Patrick Robison,Julie G Heffler,Alex K Salomon,Neil A Kelly,Apoorva Babu,Michael P Morley,Kenneth B Margulies,Benjamin L Prosser

Journal of cell science 128:397-407 PubMed25472714

2014

SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.

Applications

Unspecified application

Species

Unspecified reactive species

Katrin Diesenberg,Monika Beerbaum,Uwe Fink,Peter Schmieder,Michael Krauss

Journal of leukocyte biology 93:387-94 PubMed23315425

2013

Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2.

Applications

Unspecified application

Species

Unspecified reactive species

Agne Babusyte,Matthias Kotthoff,Julia Fiedler,Dietmar Krautwurst
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com